Carregant...
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: Research suggests that measurable change in cerebrospinal fluid (CSF) biomarkers occurs years in advance of the onset of clinical symptoms (Beckett 2010). In this review, we aimed to assess the ability of CSF tau biomarkers (t‐tau and p‐tau) and the CSF tau (t‐tau or p‐tau)/ABeta ratio t...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2017
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464349/ https://ncbi.nlm.nih.gov/pubmed/28328043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010803.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|